Clinical Trials in Glendale, AZ
Here are the 6 most popular medical studies in glendale
IVUS GUIDED for Peripheral Artery Disease
Recruiting1 award2 criteria
Scottsdale, Arizona
The main objective of the study is to survey and improve the IVUS image quality and X-ray system interoperability by collecting Procedural Data (e.g. raw, pre- processed ultrasound and X-ray data, endpoints such as fluoroscopy time, contrast load and radiation dose, workflow details) during routine intravascular procedures to assure adherence to the high standards of quality during care delivery and promote procedural standardization.
Exoskeleton Users for Paraplegia
Recruiting1 award3 criteria
Mesa, Arizona
The purpose of this study is to observe current exoskeleton users in their home environment to determine the activities of daily living (ADLs) they are able to complete, and to identify the minor adaptations to the home environment that will improve the exoskeleton user's potential for increased independence. This is a pilot study to fine-tune the methods and to determine the feasibility of doing this study on a larger scale.
Popular filter options for glendale trials
Phase 3 Clinical Trials
View 97 phase 3 medical studies.
Corticosteroid
Budesonide +1 More for Chronic Obstructive Pulmonary Disease
Recruiting2 awardsPhase 3
Glendale, Arizona
This trial will compare the effect of using a combination inhaler (BGF) containing three types of medication versus a different combination inhaler (GFF) in people with COPD and high risk for
Clinical Trials With No Placebo
View 97 medical studies that do not have a placebo group.
Corticosteroid
Budesonide +1 More for Chronic Obstructive Pulmonary Disease
Recruiting2 awardsPhase 3
Glendale, Arizona
This trial will compare the effect of using a combination inhaler (BGF) containing three types of medication versus a different combination inhaler (GFF) in people with COPD and high risk for
Observational (blood collection, bone marrow aspirate) for Acute Myeloid Leukemia
Recruiting1 award2 criteria
Scottsdale, Arizona
This study investigates the immune profile of patients receiving treatment with venetoclax plus azacitidine for acute myeloid leukemia (AML). Studying the information gathered from the immune profile from blood and bone marrow samples may help researchers understand the associated responses to the treatment of patients undergoing therapy of venetoclax plus azacitidine and create future immune based treatment approaches.
Cincinnati Children's Hospital Comprehensive Epilepsy Center for Epilepsy
Recruiting1 award1 criteria
Phoenix, Arizona
The Epilepsy Learning Health System (ELHS) is a quality improvement and research network to improve outcomes for people with epilepsy. The ELHS is designed as a model of value-based chronic care for epilepsy as envisioned by the National Academies of Medicine Committee in their landmark reports "The Learning Health System" and "Epilepsy Across the Spectrum: Promoting Health and Understanding". The ELHS network is a collaboration among clinicians, patients and researchers that promotes the use of data for multiple purposes including one-on-one clinical care, population management, quality improvement and research. The ELHS Registry includes data on children and adults with epilepsy collected during the process of standard epilepsy care. These data are used to create population health reports and to track changes in outcomes over time. ELHS teams use quality improvement methods, such as Plan-Do-Study-Act (PDSA) cycles, to continuously learn how to improve care.
Single cohort of MS patients with EDSS 1.0-4.5 for Multiple Sclerosis
Recruiting1 award6 criteria
Phoenix, Arizona
The overarching goal of this research protocol is to validate the effectiveness of Innodem's ETNA-MS device in informing clinicians on the disability status of Multiple Sclerosis (MS) patients. Effectiveness of the device will be assessed by the level of agreement between the EDSS estimated by the device and the actual scores measured by the neurologist in-person assessments.
Behavioral Intervention
Acceptance and Commitment Therapy for Blood Cancers
Recruiting1 award
Scottsdale, Arizona
"This trial is testing if acceptance and commitment therapy and compassion-based virtual group therapy can help improve the mental well-being of cancer patients. Cancer diagnosis and treatment can lead to distress and decreased quality of life,
View More Glendale Trials
See another 76 medical studies focused on glendale.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.